MAPT and Alzheimer disease: Taken together, our data demonstrate that both N- and C-terminal modulations in cholinesterases have profound roles in AD pathogenesis and that they all affect key features of AD including amyloid oligomerization, amyloid toxicity, plaque formation, tau hyperphosphorylation, apoptosis, and learning and memory impairments (Figure 3).